During his Senate confirmation hearings, Health Secretary Robert F. Kennedy Jr. suggested he wouldn’t undermine vaccines. “I ...

Writing in JAMA, four former government officials warn that the Trump administration’s involvement in delaying the approval ...

Retail investor chatter around vaccine makers Novavax, Moderna, and Pfizer rose on Wednesday, ahead of a closely watched CDC ...

Respiratory syncytial virus (RSV) causes severe illness in millions of young children each year.1 Globally, it is estimated that over 100 000 children younger than 5 years die each year from RSV; 97% ...

The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...

Millions of individuals suffering from long-haul COVID-19, relentless fatigue, brain fog, and shortness of breath can now access a groundbreaking telehealth solution designed to ...

Shares of Novavax Inc. NVAX rose 2.85% to $6.49 Tuesday, on what proved to be an all-around positive trading session for the ...

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Novavax Inc. closed 64.57% short of its 52-week high of $17.81, which the company achieved on July 26th.

Shares of San Diego-based Cidara Therapeutics Inc. (NASDAQ:CDTX) were trading at $40.41, up $19.39, or 92%, on positive top-line results from its randomized, double-blind, placebo-controlled phase IIb ...

The U.S. FDA approved 14 drugs in May, a decline from 20 in April and 22 in March. That brings the year-to-date total for 2025 to 84 approvals, the second highest on record for this period, just ...